KARYOPHARM THERAPEUTICS (KPTI) 09/06/2016 http://www.karyopharm.com/ Pipeline: Focus on treatment of cancer and other diseases. Product Indication Status Selinexor (single and in combination) Hematological malignancies and Solid tumors. Phase 2/3 KPT-8602 Multiple myeloma Phase 1 KPT-9274 Lymphoma and Solid tumors Phase 1 KPT-350 ALS, MS,Lupus, TBI Pre-clinical verdinexor (KPT-335) Influenza Phase 1 52-Week High: $19.407 (11/27/2015) 52-Week Low: $4.83 (02/09/2016) Current price: $8.94
http://www.karyopharm.com/ Pipeline: Focus on treatment of cancer and other diseases. Product Indication Status Selinexor (single and in combination) Hematological malignancies and Solid tumors. Phase 2/3 KPT-8602 Multiple myeloma Phase 1 KPT-9274 Lymphoma and Solid tumors Phase 1 KPT-350 ALS, MS,Lupus, TBI Pre-clinical verdinexor (KPT-335) Influenza Phase 1 52-Week High: $19.407 (11/27/2015) 52-Week Low: $4.83 (02/09/2016) Current price: $8.94
